Research ArticleHEALTH AND MEDICINE

ROS-responsive chitosan-SS31 prodrug for AKI therapy via rapid distribution in the kidney and long-term retention in the renal tubule

See allHide authors and affiliations

Science Advances  09 Oct 2020:
Vol. 6, no. 41, eabb7422
DOI: 10.1126/sciadv.abb7422
PDF Container

Stay Connected to Science Advances

Navigate This Article